Arch Craniofac Surg.  2022 Apr;23(2):71-76. 10.7181/acfs.2022.00185.

Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum

• Kim YG
• Oh JW
• Lee KC
• Yoon SH

• KMID: 2529206
• DOI: http://doi.org/10.7181/acfs.2022.00185

Abstract

Background
Xanthelasma palpebrarum (XP) is a benign periorbital lesion. The relationship between xanthelasma lesion size and serum cholesterol levels has been poorly studied. In this study, we investigated this relationship in the context of the clinical etiology of XP. Methods: We retrospectively reviewed medical records and pathology reports of all patients treated for XP at our hospital between June 2014 and June 2021; the data were used to analyze lesion size, underlying disease, serum cholesterol, and disease recurrence.
Results
The mean values for patient age, serum cholesterol, and lesion size were 53.0 years, 235.0 mg/dL, and 69.2 mm2, respectively. XP mainly occurred in women (64.7%); furthermore, the incidence of XP and lesion size was greatest among patients in their 5th decade of life (41.2%). There was no statistically significant relationship between xanthelasma lesion size and serum cholesterol level.
Conclusion
This study compared lesion size with various clinical features in XP patients. In patients who underwent surgery for XP, serum cholesterol levels tended to be higher than those in the general population. However, the trend between the size of XP and serum cholesterol level was unclear. Therefore, if a patient with XP visits the hospital for surgery, it is recommended to check the lipid profile to confirm underlying dyslipidemia regardless of the size.

Keyword

Dyslipidemia / Foam cells / Hypercholesterolemia / Xanthoma